z-logo
Premium
Association of common ATM polymorphism with bilateral breast cancer
Author(s) -
Heikkinen Katri,
Rapakko Katrin,
Karppinen SannaMaria,
Erkko Hannele,
Nieminen Pentti,
Winqvist Robert
Publication year - 2005
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.20996
Subject(s) - breast cancer , allele , loss of heterozygosity , cancer research , ataxia telangiectasia , biology , ovarian cancer , germline , exon , genetics , haploinsufficiency , cancer , gene , dna damage , phenotype , dna
Abstract The ATM kinase has an essential role in maintaining genomic integrity. Loss of both ATM alleles results in ataxia‐telangiectasia (A‐T), a rare autosomal recessive neuroimmunologic disorder associated with cancer susceptibility. Individuals heterozygous for germline ATM mutations have been reported to have an increased risk for malignancy, in particular, female breast cancer. In the current study, a full mutation analysis of the ATM gene was carried out in patients from 121 breast or breast‐ovarian cancer families. We discovered that the combination of 5557G→A in cis position with IVS38‐8 T→C was associated with bilateral breast cancer (OR = 10.2; 95% CI = 3.1–33.8; p = 0.001). As the 5557G→A change has been reported to affect an exonic splicing enhancer, we hypothesized that the observed composite allele could have some effect on the correct splicing of exon 39. However, no aberrant transcripts were detected, but ATM expression levels of lymphoblast cell lines from heterozygous carriers of this combination allele were lower than from noncarriers ( p = 0.09). Lowered gene expression levels may have direct influence on the activities in DNA damage recognition and response pathways, as well as other genome integrity maintenance functions. Based on the results, we propose a cancer risk‐modifying effect for the ATM 5557G→A, IVS38‐8T→C composite allele. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here